Q1 2025 Cascades Inc Earnings Call Transcript
Key Points
- Year-over-year consolidated EBITDA increased by 21%, driven by stronger pricing in packaging activities.
- Sales increased by 4% year over year, with selling prices and exchange rates offsetting negative volume impacts.
- Lower raw material costs benefited manufacturing results by $10 million.
- The company expects favorable OCC pricing in the coming months due to increased fiber availability.
- Cascades Inc (CADNF) has reinitiated near-term guidance, indicating confidence in navigating tariff discussions and macroeconomic uncertainties.
- Sales levels decreased by 5% from Q4 due to lower volumes, despite favorable exchange rates and average selling prices.
- Consolidated EBITDA decreased by 14% from Q4, impacted by lower volumes and higher operational costs.
- First-quarter sales in the tissue business decreased by 8% sequentially, driven by lower volumes.
- The Bear Island facility is behind its scheduled ramp-up objective, affecting production levels.
- Net debt increased by $120 million in the first quarter, primarily due to higher working capital requirements.
(spoken in French) Good morning. My name is Sylvie, and I will be your conference operator today. At this time, I would like to welcome everyone to Cascades first-quarter 2025 financial results conference call. All lines are currently in listen-only mode. After the speaker's remarks, there will be a question and answer session. I will now pass the call to Jennifer Aitken, director of investor relations for Cascades. Ms. Aitken, you may begin the conference.
Thank you, operator. Good morning, everyone, and thank you for joining our first quarter 2025 conference call. We will begin with an overview of our operational and financial results followed by some concluding remarks, after which we will begin the question period.
Today's speakers will be Hugues Simon, President and CEO; and Allan Hogg, CFO. Joining us for the question period at the end of the call are Jean-David Tardif, Executive Vice President Packaging; and Jerome Porlier, Executive Vice President, Tissue.
Before I turn the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
